Isoform-specific C-terminal phosphorylation drives autoinhibition of Casein Kinase 1
preprint
OA: closed
CC-BY-NC-ND-4.0
Abstract
Casein kinase 1 δ (CK1δ) controls essential biological processes including circadian rhythms and Wnt signaling, but how its activity is regulated is not well understood. CK1δ is inhibited by autophosphorylation of its intrinsically disordered C-terminal tail. Two CK1 splice variants, δ1 and δ2, are known to have very different effects on circadian rhythms. These variants differ only in the last 16 residues of the tail, referred to as the extreme C-termini (XCT), but with marked changes in potential phosphorylation sites. Here we test if the XCT of these variants have different effects in autoinhibition of the kinase. Using NMR and HDX-MS, we show that the δ1 XCT is preferentially phosphorylated by the kinase and the δ1 tail makes more extensive interactions across the kinase domain. Mutation of δ1-specific XCT phosphorylation sites increases kinase activity both in vitro and in cells and leads to changes in circadian period, similar to what is reported in vivo . Mechanistically, loss of the phosphorylation sites in XCT disrupts tail interaction with the kinase domain. δ1 autoinhibition relies on conserved anion binding sites around the CK1 active site, demonstrating a common mode of product inhibition of CK1δ. These findings demonstrate how a phosphorylation cycle controls the activity of this essential kinase. Significance Subtle control of kinase activity is critical to physiologic modulation of multiple physiological processes including circadian rhythms. CK1δ and the closely related CK1ε regulate circadian rhythms by phosphorylation of PER2, but how kinase activity itself is controlled is not clear. Building on the prior observation that two splice isoforms of CK1δ regulate the clock differently, we show that the difference maps to three phosphorylation sites in the variably spliced region (XCT) that cause feedback inhibition of the kinase domain. More broadly, the data suggest a general model where CK1 activity on diverse substrates can be controlled by signaling pathways that alter tail phosphorylation. These inhibitory phosphorylation sites could also be targets for new therapeutic interventions.
My notes (saved in your browser only)
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (1)
References (69)
- CK1δ homeostasis by activity-dependent shuttling and degradation of orphan kinase via crossref
- doi:10.1146/annurev-biochem-052410-090317 via crossref
- doi:10.1074/jbc.270.37.21689 via crossref
- doi:10.1074/jbc.273.3.1357 via crossref
- doi:10.3389/fonc.2014.00096 via crossref
- doi:10.1371/journal.pone.0177834 via crossref
- doi:10.1074/jbc.273.26.15980 via crossref
- doi:10.1073/pnas.0604138103 via crossref
- doi:10.1074/jbc.m204499200 via crossref
- doi:10.1128/mcb.00338-09 via crossref
- doi:10.1073/pnas.0906651106 via crossref
- doi:10.1016/j.molcel.2021.01.006 via crossref
- doi:10.1016/j.molcel.2015.08.022 via crossref
- doi:10.1016/j.jbc.2023.102929 via crossref
- doi:10.1016/j.molcel.2017.07.017 via crossref
- doi:10.1038/s41467-022-31715-4 via crossref
- doi:10.1016/j.jbc.2024.107391 via crossref
- doi:10.1126/science.1057499 via crossref
- doi:10.1016/j.cell.2006.11.043 via crossref
- doi:10.1016/j.molcel.2023.04.019 via crossref
- doi:10.1038/s41589-020-0600-3 via crossref
- doi:10.7554/elife.52343 via crossref
- doi:10.1126/science.288.5465.483 via crossref
- doi:10.1126/science.3413487 via crossref
- doi:10.1038/nature03453 via crossref
- doi:10.1073/pnas.1721371115 via crossref
- doi:10.1073/pnas.1721076115 via crossref
- doi:10.1038/ncomms13250 via crossref
- doi:10.1074/mcp.m800588-mcp200 via crossref
- doi:10.1126/sciadv.adj5185 via crossref
- doi:10.1093/nar/gku1267 via crossref
- doi:10.1107/s0907444997011724 via crossref
- doi:10.1002/cmr.a.21327 via crossref
- doi:10.1007/s10858-008-9296-5 via crossref
- doi:10.1038/nprot.2013.102 via crossref
- doi:10.1073/pnas.2006382117 via crossref
- doi:10.1042/bst20130250 via crossref
- doi:10.1039/c0cs00113a via crossref
- doi:10.1038/s41592-019-0459-y via crossref
- doi:10.1016/bs.mie.2022.03.037 via crossref
- doi:10.1093/emboj/16.18.5572 via crossref
- doi:10.1016/s0022-2836(02)01003-3 via crossref
- doi:10.1016/j.jmb.2005.08.029 via crossref
- doi:10.1016/j.sbi.2006.10.011 via crossref
- doi:10.3389/fmolb.2018.00039 via crossref
- doi:10.3390/biom9030081 via crossref
- doi:10.1038/s41598-023-43515-x via crossref
- doi:10.1073/pnas.2021174118 via crossref
- doi:10.1073/pnas.2316858121 via crossref
- doi:10.1159/000087137 via crossref
- doi:10.1136/gut.2007.123695 via crossref
- doi:10.1128/mcb.01466-10 via crossref
- doi:10.1016/j.ceb.2014.08.003 via crossref
- doi:10.1073/pnas.032468199 via crossref
- doi:10.1186/1476-4598-13-231 via crossref
- doi:10.1126/scitranslmed.aac4964 via crossref
- doi:10.1006/prep.1998.1003 via crossref
- doi:10.1186/1472-6750-8-91 via crossref
- doi:10.1107/s0907444910045749 via crossref
- doi:10.1107/s0021889807021206 via crossref
- doi:10.1107/s0907444910007493 via crossref
- doi:10.1016/j.ymeth.2011.07.005 via crossref
- doi:10.3791/56623 via crossref
- doi:10.1007/bf00197809 via crossref
- doi:10.1002/prot.20449 via crossref
- doi:10.1021/ac8008862 via crossref
- doi:10.7554/elife.63646 via crossref
- doi:10.1016/s0092-8674(02)00741-9 via crossref
- doi:10.1093/bioinformatics/btaa677 via crossref
Source provenance
- crossref
- last seen: 2026-06-30T06:26:31.786846+00:00
- europepmc
- last seen: 2026-05-19T01:45:01.086888+00:00
- unpaywall
- last seen: 2026-05-22T02:00:06.705733+00:00
License: CC-BY-NC-ND-4.0